Alternative splicing of uromodulin enhances mitochondrial metabolism for adaptation to stress in kidney epithelial cells
Journal of Clinical Investigation · 16.06.2025 · 135 (12)
DOI: 10.1172/jci183343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 08.04.2025. Verfasst von Azuma Nanamatsu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology and Hypertension. Hauptthemen laut MEDLINE: Uromodulin, Alternative Splicing, Mitochondria, Acute Kidney Injury. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
In the kidney, cells of thick ascending limb of the loop of Henle (TAL) are resistant to ischemic injury, despite high energy demands. This adaptive metabolic response is not fully understood even though the integrity of TAL cells is essential for recovery from acute kidney injury (AKI). TAL cells uniquely express uromodulin, the most abundant protein secreted in healthy urine. Here, we demonstrate that alternative splicing generates a conserved intracellular isoform of uromodulin, which contributes to metabolic adaptation of TAL cells. This splice variant was induced by oxidative stress and was upregulated by AKI that is associated with recovery, but not by severe AKI and chronic kidney disease (CKD). This intracellular variant was targeted to the mitochondria, increased NAD + and ATP levels, and protected TAL cells from hypoxic injury. Augmentation of this variant using antisense oligonucleotides after severe AKI improved the course of injury. These findings underscore an important role of condition-specific alternative splicing in adaptive energy metabolism to hypoxic stress. Enhancing this protective splice variant in TAL cells could become a therapeutic intervention for AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Nephrology and Hypertension.
- Department of Anatomy, Cell Biology and Physiology, Medicine.
- Department of Biochemistry and Molecular Biology.
- Center for Proteome Analysis.
- Center for Computational Biology and Bioinformatics.
- Cellular Response Technologies Core, and.
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- BLRD VA
- NIDDK
- Takeda Science Foundation
- VA merit
Zitieren
APA
Nanamatsu, A., Rhodes, G. J., LaFavers, K. A., Micanovic, R., Lazar, V., Khan, S., Barwinska, D., Makino, S., Zollman, A., Cheng, Y. H., Doud, E. H., Mosley, A. L., Repass, M. J., Kamocka, M. M., Baride, A., Phillips, C. L., Kelly, K. J., Eadon, M. T., Himmelfarb, J., …, & El-Achkar, T. M. (2025). Alternative splicing of uromodulin enhances mitochondrial metabolism for adaptation to stress in kidney epithelial cells. Journal of Clinical Investigation, 135(12). https://doi.org/10.1172/jci183343
Vancouver
Nanamatsu A, Rhodes GJ, LaFavers KA, Micanovic R, Lazar V, Khan S, et al. Alternative splicing of uromodulin enhances mitochondrial metabolism for adaptation to stress in kidney epithelial cells. Journal of Clinical Investigation. 2025;135(12). doi:10.1172/jci183343
BibTeX
@article{Nanamatsu2025,
author = {Nanamatsu, Azuma and Rhodes, George J and LaFavers, Kaice A and Micanovic, Radmila and Lazar, Virginie and Khan, Shehnaz and Barwinska, Daria and Makino, Shinichi and Zollman, Amy and Cheng, Ying-Hua and Doud, Emma H and Mosley, Amber L and Repass, Matthew J and Kamocka, Malgorzata M and Baride, Aravind and Phillips, Carrie L and Kelly, Katherine J and Eadon, Michael T and Himmelfarb, Jonathan and Kretzler, Matthias and Bacallao, Robert L and Dagher, Pierre C and Hato, Takashi and El-Achkar, Tarek M},
title = {Alternative splicing of uromodulin enhances mitochondrial metabolism for adaptation to stress in kidney epithelial cells},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {12},
doi = {10.1172/jci183343}
}
EUVIMED